Results 261 to 270 of about 323,060 (314)
A bioinformatic approach to characterize the vitellogenin receptor and the low density lipoprotein receptor superfamily in the newt Cynops orientalis. [PDF]
Sci RepSpinsante C +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Electronegative low-density lipoprotein
Current Opinion in Lipidology, 2004The occurrence in blood of an electronegatively charged LDL was described in 1988. During the 1990s reports studying electronegative LDL (LDL(-)) were scant and its atherogenic role controversial. Nevertheless, recent reports have provided new evidence on a putative atherogenic role of LDL(-).
Jordi Ordóñez-Llanos +2 more
openaire +3 more sources
Clinical Laboratory, 2017
Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.This study included 778 Japanese subjects who were not taking ...
Kengo Moriyama, Eiko Takahashi
openaire +3 more sources
Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.This study included 778 Japanese subjects who were not taking ...
Kengo Moriyama, Eiko Takahashi
openaire +3 more sources
Low-density lipoprotein heterogeneity
Baillière's Clinical Endocrinology and Metabolism, 1995As a key feature of the ALP, a raised level of small, dense LDL forms part of what is potentially the most common collection of lipoprotein abnormalities to influence the risk of CHD in the general population. The consistency of the association between a prevalence of small, dense LDL and increased risk of CHD is impressive, though the practical ...
openaire +3 more sources
Low Density Lipoproteins and Hypercholesterolemia
1989Coronary and vascular disease of atherosclerotic origin are the main causes of death and at the same time the most frequent reasons for early invalidity in the Federal Republic of Germany and other industrialized nations. In particular, coronary heart disease (CHD) is the major cause of death in middle-aged men.
H. Funke, G. Assmann, G. Schmitz
openaire +3 more sources
The low density lipoprotein receptor
Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1989The study of familial hypercholesterolemia at the molecular level has led to its advancement from a clinical syndrome to a fascinating experimental system. FH was first described 50 years ago by Carl Müller who concluded that the disease produces high plasma cholesterol levels and myocardial infarctions in young people, and is transmitted as an ...
openaire +3 more sources
Modified Low-Density Lipoproteins and High-Density Lipoproteins
Pathophysiology of Haemostasis and Thrombosis, 2006It has long been known that the oxidative state of the various plasma lipoproteins modulates platelet aggregability, thereby contributing to atherogenesis. Low-density lipoprotein (LDL), occurring in vivo both in the native and oxidised forms, interacts directly with platelets, by binding to specific receptors.
Franz Koller +3 more
openaire +2 more sources
Platelet Activation by Low Density Lipoprotein and High Density Lipoprotein
Pathophysiology of Haemostasis and Thrombosis, 2006Cardiovascular disease is the main cause of death and disability in the Western society. Lipoproteins are important in the development of cardiovascular disease since they change the properties of different cells involved in atherosclerosis and thrombosis. The interaction of platelets with lipoproteins has been under intense investigation. Particularly
Jan-Willem N. Akkerman +1 more
openaire +3 more sources